Cunningham, C.; Bolcaen, J.; Bisio, A.; Genis, A.; Strijdom, H.; Vandevoorde, C.
Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer. Pharmaceuticals 2023, 16, 219.
https://doi.org/10.3390/ph16020219
AMA Style
Cunningham C, Bolcaen J, Bisio A, Genis A, Strijdom H, Vandevoorde C.
Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer. Pharmaceuticals. 2023; 16(2):219.
https://doi.org/10.3390/ph16020219
Chicago/Turabian Style
Cunningham, Charnay, Julie Bolcaen, Alessandra Bisio, Amanda Genis, Hans Strijdom, and Charlot Vandevoorde.
2023. "Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer" Pharmaceuticals 16, no. 2: 219.
https://doi.org/10.3390/ph16020219
APA Style
Cunningham, C., Bolcaen, J., Bisio, A., Genis, A., Strijdom, H., & Vandevoorde, C.
(2023). Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer. Pharmaceuticals, 16(2), 219.
https://doi.org/10.3390/ph16020219